DTC Lite: 3 Devices (6 billing codes)
DTC LITE are three (3) individual and evidence-based FDA Cleared modalities that identify and measure the autonomic nervous system (ANS), diabetic peripheral neuropathy (DPN), peripheral arterial disease (PAD), tilt table (optional) and also includes:
Three separate devices (ANS+DPN+PAD)
Four assessments
Six eligible billing codes (not including office visits)
New 2023 Guidelines (diabetes, prediabetes, obesity, hypertension, and metabolic syndrome)
One (1) year of practice consulting up to 1 hour monthly
One (1) year license as a Diabetes Testing Center™
One (1) year extended manufacturer warranty
Dramatically Significant Outcomes
Features of the tests:
Non-Invasive
3-minutes or less each to complete
FDA Cleared with recommended billing codes
Easy to interpret color-coded reports
Allows provider to perform and bill for up to 6 billing codes
3 Test with 6 Billing Codes
Maximize Your Reimbursements
The DM Flow/Trio are three (3) individual medical devices with three (3) individual reports (as required by CMS).
Both of Our Diabetic Foot Exams are Reimbursable by Medicare
1. The Diabetic Neuropathy Device™ www.DPNtest.org is a groundbreaking FDA-cleared innovation that serves as a comprehensive solution for identifying and measuring peripheral neuropathy for both large and small fiber neuropathy. This device is a game-changer in the field of diabetic neuropathy, offering a multi-objective approach that enhances precision and accuracy in diagnosis. With this innovative device, healthcare professionals can provide earlier and more effective intervention to patients with diabetic neuropathy, who previously had limited options for treatment. This device is a true breakthrough in medical technology, and it has the potential to significantly improve the lives of those suffering from this debilitating condition.
Identify Heart Attacks and Strokes Early
2. The Autonomic Nervous System (ANS) device www.ANStest.org is an FDA-cleared medical device that measures arterial stiffness, vascularization, and endothelial function. It evaluates the functioning of the Autonomic Nervous System, which regulates many of the body's internal processes, providing accurate and reliable data to help doctors make informed decisions about their patients' health.
Prevent Lower-Extremity Amputations
3. Peripheral Artery Disease (PAD) is a condition that affects the arteries supplying blood to the legs. TruPAD™ www.TruPAD.org is a medical device that can be used to measure and diagnose PAD. This condition occurs when the arteries become narrow or clogged with plaque, which can constrict blood flow. If left untreated, PAD can lead to serious complications, such as leg pain, difficulty walking, and even amputation. However, early detection and treatment can help prevent these complications and improve overall quality of life. Using TruPAD™ is a great way to monitor and manage this condition, and it can be a valuable tool for healthcare professionals and patients alike.
Below is a financial pro forma for a popular bundle:
Financial Pro Forma
Note: Does not include revenue from office visits.
1 DM Patient ≈ $500
$5K Day* (10 DM Patients x $500)
$110K Monthly ($5K x 22 Days)
$1.3 Million Yearly ($110K x 12 Months)
10 DM Patients ≈ 40 Standard Patients
Major Causes
- Diabetes
- High Blood Pressure
- Smoking History
- High Cholesterol
Get Tested If
- You have DM
- Over age 65
- Over age 50 and have a history of diabetes or smoking
- Under age 50, but have diabetes and other PAD risk factors, such as obesity or high BP
Competitive Advantages
- Individual Exams and Reports
